To study the metabolism of thyrotropin-releasing hormone (TRH) in vivo, 400 µg TRH was administered intravenously to eight normal male subjects. Multiple plasma and urine samples were obtained before and after TRH administration. Serum TSH concentrations increased after TRH administration in all subjects. Plasma TRH levels, measured by radioimmunoassay, were undetectable (< 0.4 ng/ml) before TRH administration. Plasma TRH concentrations averaged 33±7 ng/ml (mean ±SEM) 2 min after TRH injection. Thereafter, they decreased rapidly so that the mean plasma TRH level was 2.9 ng/ml 20 min after TRH administration. The fall in plasma TRH levels was linear during this interval. Thereafter TRH levels declined more slowly. The mean half-life (t½) of TRH was 5.3±0.5 min. The mean distribution volume was 15.7±3.8 liters, an average of 16.5% of body weight in these subjects. In the urine, 5.5±0.9% of the administered TRH was recovered in the 3 h after TRH administration. Of the total urinary TRH recovered, 84.9% was excreted in the first 30 min. These results indicate that TRH is distributed in a large volume, that it is rapidly metabolized and that a significant quantity of administered TRH is excreted in the urine. Medicine, Philadelphia, Pennsylvania 19104 A B S T R A C T To study the metabolism of thyrotropinreleasing hormone (TRH) in vivo, 400 Ag TRH was administered intravenously to eight normal male subjects. Multiple plasma and urine samples were obtained before and after TRH administration. Serum TSH concentrations increased after TRH administration in all subjects. Plasma TRH levels, measured by radioimmunoassay, were undetectable (< 0.4 ng/ml) before TRH administration. Plasma TRH concentrations averaged 33±7 ng/ml (mean +SEM) 2 min after TRH injection. Thereafter, they decreased rapidly so that the mean plasma TRH level was 2.9 ng/ml 20 min after TRH administration. The fall in plasma TRH levels was linear during this interval. Thereafter TRH levels declined more slowly. The mean half-life (ti) of TRH was 5.3±0.5 min. The mean distribution volume was 15.7 ±3.8 liters, an average of 16.5% of body weight in these subjects. In the urine, 5.5±0.9% of the administered TRH was recovered in the 3 h after TRH administration. Of the total urinary TRH recovered, 84.9% was excreted in the first 30 min. These results indicate that TRH is distributed in a large volume, that it is rapidly metabolized and that a significant quantity of administered TRH is excreted in the urine.
INTRODUCTION
The administration of thyrotropin-releasing hormone (TRH)' to normal subjects is followed by a prompt increase in serum thyrotropin (TSH) concentrations.
Peak TSH levels are found 20-30 min after TRH administration and they then decline rapidly (1, 2) . These results, plus the observations that TRH is inactivated Received for publication 21 November 1972 and in revised form 12 January 1973. rapidly by human plasma or serum in vitro (3, 4) , suggested that TRH rapidly disappears from the circulation in vivo. The present study was undertaken to determine the magnitude of plasma TRH concentrations that follow its intravenous administration and its rate of disappearance and metabolic fate. METHODS Study protocol. Eight normal male subjects 17-32-yr old each received a bolus intravenous injection of 400 ug TRH. None were receiving any medications. Six were normal weight and two were obese. None had any clinical evidence of thyroid disease, and all had normal serum T4, Ts, and TSH concentrations (Table I ). Blood was obtained for TSH and TRH determinations -5, 0, 2, 5, 10, 15, 20, 30, 45, 60, 90, and 120 min after TRH administration. 5-ml samples for TRH assay were collected in tubes containing heparin and 5.0 mg 2,3-dimercaptopropanol (BAL). These samples were immediately placed in an ice bath and centrifuged within 2 min after collection for 5 min at 20C, and the plasma was frozen immediately. It previously has been shown (5) , and further data is presented below, that BAL, in a concentration of 0.5 mg/ml plasma or higher, prevents TRH inactivation by serum at 370C for at least 1 hr. Urine samples were collected for 60-120 min before and at 30-60-min intervals for 3 h after TRH administration. Immediately after collection of urine the volume was measured, and a portion was frozen.
Measurements. Serum TSH and Ts concentrations were measured by radioimmunoassay (6, 7), and thyroxine was assessed by competitive protein-binding analysis (8) . Plasma and urine TRH was measured by a sensitive and specific radioimmunoassay (9) , all samples from an individual subject being assayed at the same time. The assay sensitivity at the time of these studies was 10 pg. Plasma samples were assayed in 10-and 25-Al volumes since control plasma samples containing 1 mg/ml BAL assayed in these volumes contained no detectable TRH (< 0.4 ng/ml The results of extensive studies of the serum inactivation of TRH immunological activity have been reported from this laboratory (4). However, most of these studies were done using a large quantity of TRH (2 /sg/ml serum). When the plasma TRH results described herein became available, TRH, in a concentration (40 ng/ml) near that calculated at zero time (Table II) , was added to eight normal plasma samples and portions were removed after varying intervals of incubation at 375C. These portions were diluted 10-fold with 0.25% bovine serum albumin (BSA), 0.01 M P04, 0.15 M NaCl, pH 7.5, and their TRH content determined. The calculated rate of disappearance of this quantity of TRH in vitro was 4.1%,/min, a value similar to that previously found in experiments in which the added TRH concentration was 2 Asg/ml (6.2%/min) (4).
The effect of urine on TRH immun )logical activity was determined by incubation of TRH (20 ng/ml) in portions of fresh urine from five normal human subjects at 4, 22, and 370C. Portions were removed for imniunoassay before and Because of these results, urine samples from subjects receiving TRH were not modified, though they were frozen as rapidly as possible after collection. Since some randomly collected urine samples in doses of 50-200 /Al nonspecifically inhibited the TRH assay, all urine samples were assayed in sinaller quantities. In the urine samples collected from 0 to 3() and 30 to 60 min after TRH administration, extensive dilution was needed for quantitation of urinary TRH.
RESULTS
TRH was readily demonstrable in plasma 2 min after intravenous TRH administration. Thereafter the plasma TRH concentrations declined rapidly (Fig. 2 ). The mean plasma TRH level was 33 ng/ml 2 min after TRH (2) , are shown at the bottom of this figure. There was no correlation between the peak plasma TRH and peak serum TSH concentrations. When the mean plasma TRH levels were plotted semilogarithmically (Fig. 3) (Fig. 4) . The overall recovery averaged 21.9 lyg or 5.5% of the administered dose. Of this, an average of 18.6 isg (84.9% of the recovered TRH) was excreted in the first 30 min and 2.6 ig (11.9%) during the second 30 min after TRH administration.
DISCUSSION
These studies demonstrate that TRH disappears from the circulation very rapidly, over 90% being removed within the first 20 min after intravenous TRH administration. The variability of the ti results, from subject to subject, was not marked though in one obese subject (T. H.) low plasma TRH concentrations were found, which led to a high distribution volume estimate. The in vitro studies described suggest that the measured plasma and urine TRH concentrations were not artifactually reduced by inactivation of TRH after collection of the blood and urine samples. Thus, these results appear to give a true picture of the degradation of pharmacological quantities of TRH in man. In the only other report concerning TRH metabolism in human subjects, plasma The calculated volume of distribution of TRH averaged 16.5% of the body weight. This value corresponds closely with current estimates of extracellular fluid volume in normal human subjects (11) . The finding of a large TRH distribution volume is not unexpected in view of the small molecular size of TRH and the lack of evidence for binding of TRH to plasma protein (4, 12) .
The distribution volume result further suggests that there is little early intracellular penetration of TRH.
The rapid disappearance of TRH from plasma is undoubtedly a result of several metabolic processes. These include plasma and perhaps tissue destruction of TRH and renal excretion of TRH. TRH immunological activity is rapidly destroyed by incubation with plasma in vitro, and there is little reason to doubt the same occurs in vivo. The mean fractional rate of turnover of TRH in vivo, 13.1%/min, is roughly three times the rate of destruction of TRH by plasma in vitro. \While it has been shown that homogenates of rat tissue destroy TRH biological and immunological activity (13, Bassiri and Utiger, unpublished observations), for reasons stated above it is unlikely that a substantial quantity of TRH enters cells. Administration of [14C]TRH and [3H]TRH to animals has been shown to result in tissue accumulation of radioactivity (tissue/plasma ratios > 1) in anterior pituitary, liver, and kidney but this radioactivity was not identified as TRH per se (14) . It is possible even this radioactivity is not intracellular, but rather bound to the cell surface.
In these normal subjects, renal excretion accounted for 
